| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Furlong Tammy | CHIEF FINANCIAL OFFICER | C/O ELEVATION ONCOLOGY, INC., 101 FEDERAL STREET, SUITE 1900, BOSTON | /s/ Robert Yang, Attorney-in-Fact | 19 May 2025 | 0001984204 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ELEV | Common Stock | Options Exercise | +2,643 | +32% | 10,859 | 15 May 2025 | Direct | F1 | ||
| transaction | ELEV | Common Stock | Tax liability | $235 | -784 | -7.2% | $0.2998 | 10,075 | 15 May 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ELEV | Restricted Stock Unit | Options Exercise | $0 | -2,343 | -8.3% | $0.000000 | 25,782 | 15 May 2025 | Common Stock | 2,343 | Direct | F1, F2, F3 | |
| transaction | ELEV | Restricted Stock Unit | Options Exercise | $0 | -300 | -12% | $0.000000 | 2,100 | 15 May 2025 | Common Stock | 300 | Direct | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. |
| F2 | 25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |
| F3 | The RSUs do not expire; they either vest or are canceled prior to the vesting date. |
| F4 | 25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |